NewsRx

Search our medical news database

Watson Pharmaceuticals, Inc.

Pharmaceutical company announces marketing partner for nicotine gum

Published in Health Business Week, March 26th, 2004

Watson Pharmaceuticals, Inc., (WPI) has entered into an agreement with Novartis Consumer Health, whereby, on Watson's behalf, Novartis will promote Watson's nicotine polacrilex gum, 2 mg and 4 mg, to specified retail outlets to which Watson does not currently promote.

Watson's nicotine polarcrilex gum is used as an aid for smoking cessation. Terms of the agreement were not disclosed.

"We are pleased to have Novartis Consumer Health as our marketing partner on our nicotine gum," said Joe Papa, Watson's president and chief operating officer. "As a result, we are now able to make this product available to those over-the-counter customers we do not...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook